1 | SALAH AZAIEZ INSTITUTE OF ONCOLOGY, SURGICAL DEPARTMENT OF ONCOLOGY, TUNIS, TUNISIA |
Endometrial cancer (EC) is the most common cancer of all gynecological malignancies. Most women are diagnosed with an earlystage disease, which generally has a good prognosis. Lymph node dissection represents a cornerstone not only for staging but also for treatment of EC.
In recent years a novel technique “Sentinel lymph node (SLN)” emerged as a valuable alternative option to lymphadenectomy. This technique has in most of the literature reports a reduced morbidity and enhanced detection of metastatic disease, due to contribution to detection of aberrant lymphatic pathways on one hand, and improvement of pathologic ultra-staging techniques on the other hand.
The current review aims to summarize the existing data on the feasibility of the SLN technique and the oncologic outcomes.
Vancouver | Sghaier S, Ghalleb M, Bouaziz H, Chemlali M, Hechiche M, Slimane M, Rahal K. Sentinel lymphnode for endometrial cancer: where are we?. J Clin Investig Surg. 2020 May 25;5(1):1-8. Available from: https://www.proscholar.org/jcis/archive/vol.5/iss.1/1/ doi: 10.25083/2559.5555/5.1/1.8 |
NLM | Sghaier S, Ghalleb M, Bouaziz H, Chemlali M, Hechiche M, Slimane M, Rahal K. Sentinel lymphnode for endometrial cancer: where are we?. J Clin Investig Surg. 2020 May;5(1):1-8. doi: 10.25083/2559.5555/5.1/1.8. |
AMA | Sghaier S, Ghalleb M, Bouaziz H, Chemlali M, Hechiche M, Slimane M, Rahal K. Sentinel lymphnode for endometrial cancer: where are we?. J Clin Investig Surg. 2020;5(1):1-8. |
MLA | Sghaier, Sarah, et al. “Sentinel lymphnode for endometrial cancer: where are we?.” Journal of Clinical and Investigative Surgery 5.1 (2020): 1-8. doi:10.25083/2559.5555/5.1/1.8. |
APA | Sghaier, S., Ghalleb, M., Bouaziz, H., Chemlali, M., Hechiche, M., Slimane, M., & Rahal, K. (2020). Sentinel lymphnode for endometrial cancer: where are we?. Journal of Clinical and Investigative Surgery, 5(1), 1-8. |
ISO 690 | Sghaier , Sarah, et al. Sentinel lymphnode for endometrial cancer: where are we?. Journal of Clinical and Investigative Surgery, 2020, 5.1: 1-8. |